Immunovant, Inc. (IMVT)
26.13
-0.14
(-0.53%)
USD |
NASDAQ |
Jan 20, 16:00
25.71
-0.42
(-1.61%)
After-Hours: 20:00
Immunovant Total Liabilities (Quarterly): 63.25M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Revvity, Inc. | 4.763B |
| Viridian Therapeutics, Inc. | 74.17M |
| Perspective Therapeutics, Inc. | 52.61M |
| Electromed, Inc. | 8.869M |
| InfuSystem Holdings, Inc. | 43.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 582.96M |
| Shareholders Equity (Quarterly) | 519.70M |
| Current Ratio | 9.067 |
| Net Debt Paydown Yield | 0.00% |